Lantheus Holdings, headquartered in North Billerica, Massachusetts, specializes in diagnostic imaging and nuclear medicine products, focusing on oncology and precision diagnostics. The company went public in 2015 and employs 834 staff.
Paul Blanchfield sold 6,599 shares of LNTH on 5 June at $79.65 per share, worth a total of $526K. They now own 111,792 LNTH shares, or a 6% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.